EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors

Polina S Ermakova, Anna A Barinova iD, Alexandra Y Bogomolova, Arseniy L Potapov iD, Polina M Zharova iD, Maxim A Baten'kin iD, Mariya Yu Zakharina, Alexey N Konev, Sergey A Chesnokov, Maria M Karabut, Vadim V Elagin iD, Alexandra N Bogomazova iD und 3 weitere

Cells · 2026

DOI: 10.3390/cells15211942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Polina S Ermakova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Federal State Budgetary Institution of Higher Education "Privolzhsky Research Medical University" of the Ministry of Health of Russia, Nizhny Novgoro…. Hauptthemen laut MEDLINE: Alginates, Induced Pluripotent Stem Cells, Pancreas, Gene Knockout Techniques. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic cell replacement therapy for diabetes using induced pluripotent stem cell (iPSC)-derived pancreatic progenitors (PPs) is currently limited by immune rejection. Alginate encapsulation and the genetic ablation of HLA-I via β2-microglobulin (B2M) knockout represent distinct strategies to reduce immune recognition and to protect the transplanted cells. We generated encapsulated B2M-knockout pancreatic progenitors (IPS-∆B2M-PPs) and evaluated their immunogenicity in vitro using each of: peripheral blood mononuclear cell (PBMC) co-culture, natural killer cell (NK cell) degranulation, T-cell activation, and rat macrophage adhesion. In vivo studies were also performed to assess capsule biocompatibility and structural stability, following transplantation into rat omentum. While the B2M knockout did not compromise differentiation to pancreatic lineage, encapsulation largely prevented NK cell degranulation regardless of the encapsulated cell type, although T-cells did show residual activation after 7 days of co-culture with encapsulated progenitors, albeit significantly reduced in comparison with non-encapsulated controls. IPS-∆B2M-PP-containing capsules showed reduced macrophage adhesion in vitro compared to wild-type progenitors, while Interleukin-1β (IL-1β) secretion by the macrophages remained negligible. In vivo, all capsules formed a myofibroblastic zone without giant foreign-body cells; IPS-∆B2M-PP implants exhibited the thinnest fibrotic capsules and minimal lymphocytic infiltration. No capsule deformation was observed at 2 weeks or 1 month, indicating preserved structural stability. Although this characterizes both the local tissue response to the biomaterial and capsule stability, it does not establish immune evasion or reduced immunogenicity of the encapsulated cells in vivo. Overall, this study demonstrates the feasibility of combining B2M knockout with alginate encapsulation and suggests a potential additional protective role for B2M deletion under conditions of compromised capsule integrity that requires further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlginatesInduced Pluripotent Stem CellsPancreasGene Knockout TechniquesGraft RejectionAnimalsRatsHumansCell DifferentiationKiller Cells, NaturalMacrophagesCoculture TechniquesMale

Stichwörter der Autor:innen

B2M knockoutIPSC-derived pancreatic progenitorsNK cell responseT-cell activationalginate encapsulationbiocompatibilitycell replacement therapydiabetes mellitusimmune rejectionmacrophage adhesion

Substanzen

Alginates

Autor:innen und Institutionen

  • Federal State Budgetary Institution of Higher Education "Privolzhsky Research Medical University" of the Ministry of Health of Russia, Nizhny Novgorod 603005, Russia.
  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow 119435, Russia.
  • Federal State Budgetary Institution of Science, G.A. Razuvaev Institute of Organometallic Chemistry Russian Academy of Sciences, Nizhny Novgorod 603950, Russia.
  • Institute of Gene Biology Russian Academy of Sciences, Moscow 119334, Russia.
  • Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119333, Russia.

ORCID-Profile: Anna A Barinova, Arseniy L Potapov, Polina M Zharova, Maxim A Baten'kin, Vadim V Elagin, Alexandra N Bogomazova, Aleksandra V Kashina

Förderung

  • Russian Science Foundation

Zitieren

APA

Ermakova, P. S., Barinova, A. A., Bogomolova, A. Y., Potapov, A. L., Zharova, P. M., Baten'kin, M. A., Zakharina, M. Y., Konev, A. N., Chesnokov, S. A., Karabut, M. M., Elagin, V. V., Bogomazova, A. N., Kashina, A. V., Panova, A. V., & Zagaynova, E. V. (2026). Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors. Cells. https://doi.org/10.3390/cells15211942

Vancouver

Ermakova PS, Barinova AA, Bogomolova AY, Potapov AL, Zharova PM, Baten'kin MA, et al. Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors. Cells. 2026. doi:10.3390/cells15211942

BibTeX
@article{Ermakova2026,
  author = {Ermakova, Polina S and Barinova, Anna A and Bogomolova, Alexandra Y and Potapov, Arseniy L and Zharova, Polina M and Baten'kin, Maxim A and Zakharina, Mariya Yu and Konev, Alexey N and Chesnokov, Sergey A and Karabut, Maria M and Elagin, Vadim V and Bogomazova, Alexandra N and Kashina, Aleksandra V and Panova, Alexandra V and Zagaynova, Elena V},
  title = {Combined B2M Knockout and Alginate Encapsulation Reduces Immune Rejection of iPSC-Derived Pancreatic Progenitors},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15211942}
}
Kostenlos starten →